Thomas Russo
Gardner Russo & Quinn
Thomas Russo Colgate-Palmolive Company stake
total: 273
Gardner Russo & Quinn CL trades
- Total transactions:
- 4
- New positions:
- 2
- Sold out:
- 2
- Held since:
- 2017 Q4
- Held for:
- 1 quarter
- Latest activity:
- 2018 Q1
According to 2026 Q2 report, Thomas Russo doesn't hold any Colgate-Palmolive Company (CL) shares. To date, the estimated cost basis is nearly $75.24 for "buy" trades and estimated average "sell" price is $75.24. Gardner Russo & Quinn first purchased CL in 2014 Q1, initially acquiring 8,900 shares. Thomas Russo later completely sold out the position and invested in Colgate-Palmolive Company again in 2017 Q4. Since the initial investment in Colgate-Palmolive Company (CL), Gardner Russo & Quinn has made 3 more transactions.
When did Thomas Russo sell Colgate-Palmolive Company (CL)?
Thomas Russo sold off the entire Colgate-Palmolive Company (CL) position in 2018 Q1.
When did Thomas Russo buy Colgate-Palmolive Company (CL)?
Thomas Russo first invested in Colgate-Palmolive Company (CL) in 2014 Q1 at the reported quarter-end price of $64.83 per share.
What's the cost basis of Gardner Russo & Quinn's CL stake?
The estimated cost basis for Colgate-Palmolive Company (CL) stake is around $75.24 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $75.24
- Weighted AVG sell price:
- $75.24
Thomas Russo's historical trades in Colgate-Palmolive Company
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2018 Q1
|
0.00%
|
$75.24
|
-100% (-2,100)
|
|||
|
2017 Q4
|
0.00%
|
$75.24
|
new
|
|||
|
2014 Q2
|
0.00%
|
$64.83
|
-100% (-8,900)
|
|||
|
2014 Q1
|
0.01%
|
$64.83
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.